TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH

It is used as enzyme replacement therapy for the treatment of Hunter syndrome (mucopolysaccharidosis II) in adult and pediatric patients with low levels of the iduronate-2-sulfatase enzyme.

Dosage form: solution for infusion, concentrate

ATC: A16AB09

It is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years.

Dosage form: capsules, modified release, hard

ATC: N06BA04

It is used to treat the symptoms of hereditary angioedema (HAE) in adults, adolescents, and children from 2 years of age. It works by blocking bradykinin to stop the swelling, pain, nausea, and diarrhea typical of attacks.

Dosage form: solution for injection

ATC: B06AC02

It is used to reduce phosphate levels in the blood in adults with chronic kidney disease.

Dosage form: tablets, chewable

ATC: V03AE03

It is used to treat adult patients with colon or rectal cancer that has spread to other parts of the body (metastatic), in cases where other treatments have not worked or are not suitable.

Dosage form: capsules, hard gelatin

ATC: L01EK04

It is used to treat adults who have undergone an organ or bone marrow transplant and have developed a cytomegalovirus (CMV) infection that has not cleared or has recurred after the use of another antiviral drug.

Dosage form: tablets, film-coated

ATC: J05AX10

It is a hormone replacement therapy for adults with hypoparathyroidism, a condition caused by low levels of parathyroid hormone, which controls calcium and phosphate in the blood and urine.

Dosage form: solution for injection, powder and solvent

ATC: H05AA03

It is used in adults to treat adrenal insufficiency (or cortisol deficiency), a condition in which the adrenal glands do not produce a sufficient amount of natural cortisol.

Dosage form: tablets, modified release

ATC: H02AB09

It is a vaccine used to protect adults, adolescents, and children (from 4 years of age and older) against dengue, a disease caused by four different types of dengue virus.

Dosage form: solution for injection, powder and solvent

ATC: J07BX04

It is used for the long-term treatment of adults, adolescents, and children over 7 years of age with a confirmed diagnosis of Fabry disease, when enzyme levels in the body are absent or below normal.

Dosage form: solution for infusion, concentrate

ATC: A16AB03

It is used for the treatment of chronic constipation in adults when laxatives are not effective.

Dosage form: tablets, film-coated

ATC: A06AX05

Revestive is used to improve the absorption of nutrients and fluids by the intestine in adults, children, and adolescents suffering from short bowel syndrome.

Dosage form: solution for injection, powder and solvent

ATC: A16AX08

TAKHZYRO is used to prevent angioedema attacks (HAE) in patients aged 2 years and older.

Dosage form: solution for injection

ATC: B06AC05

VPRIV is an enzyme replacement therapy used for the long-term treatment of patients with type 1 Gaucher disease, a genetic condition caused by a deficiency or malfunction of the glucocerebrosidase enzyme.

Dosage form: solution for infusion, powder for preparation

ATC: A16AB10

It is used for the treatment of essential thrombocythemia, a disorder in which the bone marrow produces too many platelets, causing potential circulation and clotting problems.

Dosage form: capsules, hard gelatin

ATC: L01XX35